Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.76B |
| 2 |
Tesla
TSLA
|
+$1.37B |
| 3 |
Amazon
AMZN
|
+$623M |
| 4 |
AbbVie
ABBV
|
+$398M |
| 5 |
Qualcomm
QCOM
|
+$394M |
Top Sells
| 1 |
CELG
Celgene Corp
CELG
|
+$1.54B |
| 2 |
Johnson & Johnson
JNJ
|
+$603M |
| 3 |
Micron Technology
MU
|
+$366M |
| 4 |
Meta Platforms (Facebook)
META
|
+$365M |
| 5 |
UnitedHealth
UNH
|
+$353M |
Sector Composition
| 1 | Healthcare | 21.21% |
| 2 | Technology | 12.91% |
| 3 | Consumer Discretionary | 10.45% |
| 4 | Financials | 8.47% |
| 5 | Industrials | 7.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3101
SB Financial Group
SBFG
$140M
| $262K | ﹤0.01% |
13,965
+1,260
| +10% | +$23.6K |
|
3102
Yext
YEXT
$1.08B
| $262K | ﹤0.01% |
18,146
-1,246,745
| -99% | -$18M |
|
|
BVSN
3103
DELISTED
Broadvision Inc Com
BVSN
| $262K | ﹤0.01% |
100,500
+14,500
| +17% | +$37.8K |
|
|
GENE
3104
DELISTED
Genetic Technologies Ltd.
GENE
| $259K | ﹤0.01% |
26,062
+3,523
| +16% | +$35K |
|
3105
Solid Biosciences
SLDB
$389M
| $258K | ﹤0.01% |
3,869
+1,716
| +80% | +$114K |
|
3106
Clearside Biomedical
CLSD
$26.6M
| $257K | ﹤0.01% |
+88,701
| New | +$257K |
|
3107
SPDR S&P International Dividend ETF
DWX
$492M
| $257K | ﹤0.01% |
+6,400
| New | +$257K |
|
3108
Sol-Gel Technologies
SLGL
$76.7M
| $257K | ﹤0.01% |
1,499
-764
| -34% | -$131K |
|
|
AMRB
3109
DELISTED
American River Bankshares
AMRB
| $257K | ﹤0.01% |
17,302
+6,640
| +62% | +$98.6K |
|
3110
Palisade Bio
PALI
$5.22M
| $256K | ﹤0.01% |
58
+36
| +164% | +$159K |
|
3111
Sonoma Pharmaceuticals
SNOA
$7.51M
| $256K | ﹤0.01% |
2,935
+611
| +26% | +$53.3K |
|
3112
Cogent Biosciences
COGT
$1.77B
| $255K | ﹤0.01% |
88,615
+85,365
| +2,627% | +$246K |
|
3113
QuidelOrtho
QDEL
$1.93B
| $255K | ﹤0.01% |
3,400
-5,500
| -62% | -$413K |
|
3114
iShares ESG Optimized MSCI USA ETF
SUSA
$3.6B
| $255K | ﹤0.01% |
+3,800
| New | +$255K |
|
3115
Brink's
BCO
$4.79B
| $254K | ﹤0.01% |
+2,800
| New | +$254K |
|
3116
iShares International Developed Real Estate ETF
IFGL
$97.6M
| $254K | ﹤0.01% |
+8,415
| New | +$254K |
|
|
WHWK
3117
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$84.4M
| $254K | ﹤0.01% |
27,142
+16,449
| +154% | +$154K |
|
|
NWHM
3118
DELISTED
THE NEW HOME COMPANY INC.
NWHM
| $254K | ﹤0.01% |
54,500
+2,600
| +5% | +$12.1K |
|
3119
Arcturus Therapeutics
ARCT
$484M
| $253K | ﹤0.01% |
23,300
-9,200
| -28% | -$99.9K |
|
3120
Lightpath Technologies
LPTH
$233M
| $253K | ﹤0.01% |
349,095
+98,680
| +39% | +$71.5K |
|
3121
Radiant Logistics
RLGT
$304M
| $253K | ﹤0.01% |
45,507
-120,993
| -73% | -$673K |
|
3122
Oak Valley Bancorp
OVLY
$244M
| $252K | ﹤0.01% |
+12,973
| New | +$252K |
|
3123
A-Mark Precious Metals
AMRK
$605M
| $251K | ﹤0.01% |
60,600
-1,000
| -2% | -$4.14K |
|
|
ASM
3124
Avino Silver & Gold Mines
ASM
$608M
| $251K | ﹤0.01% |
434,138
+107,831
| +33% | +$62.3K |
|
3125
Marten Transport
MRTN
$946M
| $249K | ﹤0.01% |
17,400
-52,350
| -75% | -$749K |
|